Colon cancer in people under 50 is on the rise, and nobody's entirely sure why. Researchers have been poking around for clues, and a team just found something odd hiding in the tumor's plumbing: younger patients' cancers seem to have fewer blood vessels running through them.
Wait, isn't that... good? Hold that thought.
The Blood Vessel Mystery
Here's the setup. Tumors need blood vessels to grow - they're greedy little things that require constant delivery of oxygen and nutrients. This process, called angiogenesis (fancy word for "growing new blood vessels"), has been a major target for cancer drugs for decades. The logic seems straightforward: starve the tumor of its blood supply, and it withers.
But tumors are trickier than that. The relationship between blood vessels and cancer behavior is less "simple plumbing" and more "complicated relationship status." Sometimes fewer vessels mean slower growth. Sometimes it means the tumor adapted to survive in harsh, low-oxygen conditions - which can actually make it more aggressive and harder to treat.
What the Researchers Actually Did
A team spanning Harvard, Dana-Farber, and Massachusetts General Hospital analyzed tumor samples from 843 colorectal cancer patients, drawn from two massive ongoing health studies (the Nurses' Health Study and Health Professionals Follow-up Study) that have been tracking tens of thousands of Americans for decades [1].
They didn't just eyeball these samples. They used multispectral immunofluorescence imaging - basically shining multiple colored lights at the tissue to highlight different proteins simultaneously - combined with machine learning to precisely measure six different blood vessel markers. This let them map out the vascular landscape of each tumor in detail that would've been impossible a few years ago.
The proteins they tracked included CD34 (a general marker for blood vessel cells), VEGFR2 (a receptor that helps vessels grow), and several others that tell you about different types of blood vessels and their maturity.
The Age Connection
When they compared tumors from patients diagnosed at different ages, a pattern emerged. Cancers from younger patients (especially those under 50) showed lower overall blood vessel density - specifically, fewer CD34-positive vessels.
This held up even after accounting for a bunch of other factors that could muddy the waters: tumor location, stage, microsatellite instability status, and the usual suspects that researchers need to rule out before claiming a real finding.
The association was particularly strong for tumors in the proximal colon (the right side, closer to where the small intestine connects) and for tumors that weren't hypermutated.
What This Might Mean
The researchers are careful not to oversell this. Finding that younger patients' tumors have different vascular patterns doesn't tell us why early-onset colorectal cancer is increasing, or whether this vascular difference is a cause or consequence of whatever's driving that trend.
But it opens some interesting questions. Could the different blood vessel patterns in younger patients affect how well anti-angiogenic drugs work? These treatments (like bevacizumab) have been used against colorectal cancer for years, but response rates vary widely. If younger patients' tumors have fundamentally different vascular biology, that might matter for treatment planning.
There's also the environmental angle. Early-onset colorectal cancer has been linked to various modern lifestyle factors - diet, obesity, changes in gut microbiome [2, 3]. Could these factors influence tumor vascular development? The researchers note their cohorts are predominantly white healthcare professionals, so whether these findings apply more broadly remains to be seen.
The Bigger Picture
This study adds another piece to a puzzle that researchers are actively assembling. Early-onset colorectal cancer isn't just "regular colon cancer in younger people" - it appears to have its own molecular and biological personality [4]. Previous research has shown differences in tumor genetics, immune cell infiltration, and now vascular architecture.
Understanding these differences matters because treatment approaches that work well for cancers in older patients might need adjustment for younger ones. Or they might not - but you can't know without doing the work of characterizing how these tumors actually differ.
For now, the practical takeaway for non-scientists is simpler: if you're under 50 and experiencing symptoms like persistent changes in bowel habits, blood in your stool, or unexplained abdominal discomfort, don't assume you're too young for it to be serious. The age threshold for routine screening recently dropped to 45 for good reason.
References
-
Matsuda K, Ugai S, Miyahara S, et al. Tumor vessel phenotype in colorectal cancer microenvironment according to age at diagnosis. British Journal of Cancer. 2025. doi:10.1038/s41416-026-03373-6
-
Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nature Reviews Clinical Oncology. 2021;18(4):230-243. doi:10.1038/s41571-020-00445-1
-
Hofseth LJ, Hebert JR, Chanda A, et al. Early-onset colorectal cancer: initial clues and current views. Nature Reviews Gastroenterology & Hepatology. 2020;17(6):352-364. doi:10.1038/s41575-019-0253-4
-
Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. Journal of the National Cancer Institute. 2021;113(12):1683-1692. doi:10.1093/jnci/djab124
Disclaimer: This blog post is a simplified summary of published research for educational purposes. The accompanying illustration is artistic and does not depict actual model architectures, data, or experimental results. Always refer to the original paper for technical details.